Literature DB >> 23446296

Superior ophthalmic vein enlargement and increased muscle index in dysthyroid optic neuropathy.

Breno da Rocha Lima1, Julian D Perry.   

Abstract

PURPOSE: To compare superior ophthalmic vein diameter and extraocular muscle index in patients with thyroid eye disease with or without optic neuropathy.
METHODS: High-resolution CT scan images of 40 orbits of 20 patients with history of thyroid eye disease (with or without optic neuropathy), who underwent orbital decompression surgery from January 2007 to November 2009, were retrospectively reviewed. Superior ophthalmic vein diameter was measured in coronal and axial planes. Extraocular muscle index was calculated according to the method proposed by Barrett et al. The clinical diagnosis of optic neuropathy was based on characteristic signs that included afferent pupillary defect, decreased visual acuity, visual field defects, and dyschromatopsia. Orbits were divided in 2 groups based on presence or absence of optic neuropathy.
RESULTS: Superior ophthalmic vein diameter was significantly higher in orbits with concomitant optic neuropathy (mean 2.4 ± 0.4mm, p < 0.0001). Increased muscle index was also related to optic neuropathy (mean 57.9% ± 5.7%, p = 0.0002). Muscle index greater than 50% was present in all patients with dysthyroid optic neuropathy.
CONCLUSIONS: This study suggests that patients with thyroid eye disease with enlarged superior ophthalmic vein and increased extraocular muscle index are more likely to have concomitant optic neuropathy.

Entities:  

Mesh:

Year:  2013        PMID: 23446296     DOI: 10.1097/IOP.0b013e3182831bd8

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  9 in total

1.  Assessment of Orbital Computed Tomography (CT) Imaging Biomarkers in Patients with Thyroid Eye Disease.

Authors:  Shikha Chaganti; Kevin Mundy; Michael P DeLisi; Katrina M Nelson; Robert L Harrigan; Robert L Galloway; Bennett A Landman; Louise A Mawn
Journal:  J Digit Imaging       Date:  2019-12       Impact factor: 4.056

2.  Reduced choroidal peripapillary capillaries in thyroid-associated ophthalmopathy with early stage of dysthyroid optic neuropathy.

Authors:  Jia-Hui Wu; Li-Ying Luo; Hao Zhou; Ying Wu; Jian Zhang; Jin-Wei Cheng
Journal:  Int J Ophthalmol       Date:  2022-07-18       Impact factor: 1.645

Review 3.  Extraocular muscle enlargement.

Authors:  Khizar Rana; Valerie Juniat; Sandy Patel; Dinesh Selva
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-06-17       Impact factor: 3.535

4.  Structural Functional Associations of the Orbit in Thyroid Eye Disease: Kalman Filters to Track Extraocular Rectal Muscles.

Authors:  Shikha Chaganti; Katrina Nelson; Kevin Mundy; Yifu Luo; Robert L Harrigan; Steve Damon; Daniel Fabbri; Louise Mawn; Bennett Landman
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2016-03-21

5.  Effect of smoking on retrobulbar blood flow in thyroid eye disease.

Authors:  A Sadeghi-Tari; M Jamshidian-Tehrani; A Nabavi; S Sharif-Kashani; E Elhami; N Hassanpour; K Ameli Zamani
Journal:  Eye (Lond)       Date:  2016-08-19       Impact factor: 3.775

6.  RAPD as a clinical alert for early evidence of dysthyroid optic neuropathy.

Authors:  Vinita Gupta; Sucharita Das; Shalini Mohan; Udit Chauhan
Journal:  J Family Med Prim Care       Date:  2022-01-31

7.  DMs-MAFM+EfficientNet: a hybrid model for predicting dysthyroid optic neuropathy.

Authors:  Cong Wu; Shijun Li; Xiao Liu; Fagang Jiang; Bingjie Shi
Journal:  Med Biol Eng Comput       Date:  2022-09-21       Impact factor: 3.079

8.  Diagnostic Ability of Barrett's Index and Presence of Intracranial Fat Prolapse in Dysthyroid Optic Neuropathy.

Authors:  Parinee Kemchoknatee; Alisa Chenkhumwongse; Thanchanok Dheeradilok; Thansit Srisombut
Journal:  Clin Ophthalmol       Date:  2022-08-12

9.  Dysthyroid optic neuropathy: update on pathogenesis, diagnosis, and management.

Authors:  Alexander D Blandford; Dalia Zhang; Rao V Chundury; Julian D Perry
Journal:  Expert Rev Ophthalmol       Date:  2017-01-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.